MYCOF
MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW (MYCOF)
$01
About MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW (MYCOF)
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.02
52 Week Low
$0.00
Market cap
137,600
Dividend yield
0.00%
Volume
--
Avg. volume
13,885
P/E ratio
-.03
MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.02
52 Week Low
$0.00
Market cap
137,600
Dividend yield
0.00%
Volume
--
Avg. volume
13,885
P/E ratio
-.03